Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05680597 · ClinicalTrials.gov registry record · NA

Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

A NA study of Parkinson Disease, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05680597: Recruiting NA study of Parkinson Disease, sponsored by Oregon Health and Science University.

NCT05680597 is a NA study of Parkinson Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 80 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05680597, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.

Primary Outcome

The Mini-BESTest, a 14-item test of 4 domains of balance, that has been well studied and is related to fall risk in people with Parkinson's disease.

Conditions Studied

Interventions

  • OTHER Balance Tele-Rehabilitation Agility Boot Camp (ABC)

Study Locations (1)

Oregon

  • Oregon Health Science University - Portland

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-09-19
Est. Completion 2027-06
Phase NA

What NCT05680597 shows while recruiting

NCT05680597 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Balance Tele-Rehabilitation Agility Boot Camp (ABC) is the first listed.

NCT05680597 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT05680597 about?

NCT05680597 is a clinical study titled "Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease". This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.

What is the current status of trial NCT05680597?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-19. Estimated completion is 2027-06.

What conditions does trial NCT05680597 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05680597?

The interventions under investigation include: Balance Tele-Rehabilitation Agility Boot Camp (ABC) (OTHER).

Who is sponsoring clinical trial NCT05680597?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05680597 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05680597's enrollment target sits among peer trials

80 105th of 297 higher than 189 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05680597, the US trial registry maintained by the National Library of Medicine. NCT05680597 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.